• Alpha Medical

  • Sector: healthcare industry
  • Client: Penta Investments
  • Year: 2012
  • Deal value: confidential
  • Under Rothschild’s leadership CORPIN acted as the exclusive financial adviser to Penta Investments in its successful disposal of its in-vitro human laboratory diagnostic business trading under the Alpha Medical and Aeskulab brands in Slovakia, the Czech Republic and Poland.
  • In 2011/2012 Penta reviewed its significant equity investment in the healthcare sector and decided to offer to investors its matured in-vitro diagnostic business. Rothschild/ CORPIN was selected to organize competitive tender process, based primarily on Rothschild’s extensive global experience in the healthcare sector and particularly in the diagnostic services.
  • Accelerated sale process that we have organized with Rothschild has resulted in several offers from various investors and it was preceded by a thorough preparatory process, which included vendor due diligence. The Alpha Medical group was eventually acquired by funds from the MEP group towards the end of 2012.
  • Successful conclusion of this transaction meant not only a financial gain for our client Penta Investments, but also fulfilment of its ultimate strategic objective – reorganization of their healthcare interests and possibility to focus on areas with better development potential in healthcare.
  • See more in the press release here.